Novartis sells UK plant after delay, costing 212 workers their jobsnews2022-05-18T12:07:04+00:00May 18th, 2022|Fierce Pharma|
‘Startup like no other’: China’s Hengrui launches Luzsana with Big Pharma veterans at the top and a goal to improve drug accessnews2022-05-18T09:32:10+00:00May 18th, 2022|Fierce Pharma|
Novo Nordisk’s latest obesity awareness campaign has patients stress the need to ‘share the weight’news2022-05-18T06:17:32+00:00May 18th, 2022|Fierce Pharma|
J&J debuts ‘Depression Looks Like Me’ campaign by and for the LGBTQ+ communitynews2022-05-18T03:02:34+00:00May 18th, 2022|Fierce Pharma|
J&J debuts rap video, enlists Bollywood star to recruit young people for India’s TB fightnews2022-05-17T15:42:17+00:00May 17th, 2022|Fierce Pharma|
Novartis faces Greek bribery lawsuit as government prepares to seek compensationnews2022-05-17T14:37:42+00:00May 17th, 2022|Fierce Pharma|
Valneva’s COVID-19 vaccine faces uncertain future after Europe cancels supply contractnews2022-05-17T13:32:49+00:00May 17th, 2022|Fierce Pharma|
Buffett’s Berkshire backs out of AbbVie, Bristol Myers Squibb holdingsnews2022-05-17T13:30:36+00:00May 17th, 2022|Fierce Pharma|
3rd time lucky? ScPharmaceuticals gets decision date for twice-rejected on-body drug delivery productnews2022-05-17T13:26:53+00:00May 17th, 2022|Fierce Pharma|
Pfizer, Merck and AstraZeneca led Big Pharma’s growth in Q1 but they couldn’t match mRNA hotshotsnews2022-05-17T11:58:34+00:00May 17th, 2022|Fierce Pharma|
